Skip to main content
Main navigation
Home
Browse
Upcoming Live
On Demand
Podcasts
All
About Us
Login
Register
Browse
Search by Speaker, Therapeutic Area, Series...
Therapeutic Area
- Any -
Allergies
Cardiovascular
Diabetes
Neurology
Women's Health
Format
- Any -
Upcoming Live Programs
On Demand
Podcast
Accreditation
- Any -
NON-ACCREDITED
CCCEP
CFPC
FMOQ
RCPSC
Series
- Any -
Breaking News
CAN-R³: Canadian Initiative to Reduce Residual Risk
Diabetes Update 2022 - Podcast Series
HF21
Top 3 HF Conundrums
On Demand
29:24
November 4, 2021
Newly Diagnosed HF: Initiation of GDMT
Newly Diagnosed HF: Initiation of GDMT
On Demand
November 2, 2021
“I Dissent”: What Works With Non-Compliant Patients?
“I Dissent”: What Works With Non-Compliant Patients?
On Demand
1 hour
October 28, 2021
Is Colchicine the Third Pillar of Secondary Prevention of ASCVD?
Original air date: Thursday, October 28, 2021
On Demand
1:06:49
October 27, 2021
La colchicine est-elle le troisième pilier de la prévention secondaire de la MCV
La colchicine est-elle le troisième pilier de la prévention secondaire de la MCVA ?
On Demand
29:30
October 5, 2021
Is There a Right Way and a Wrong Way? Sequencing of Foundational Therapy in HFrE
Is There a Right Way and a Wrong Way? Sequencing of Foundational Therapy in HFrEF
On Demand
48:19
October 4, 2021
L’ensemble d’ordonnances de la SCIC/SQIC pour les admissions liées à l’insuffisa
L’ensemble d’ordonnances de la SCIC/SQIC pour les admissions liées à l’insuffisance cardia
On Demand
29:21
October 4, 2021
Is it Time for Device Implantation yet?
Is it Time for Device Implantation yet?
On Demand
1:00:22
September 30, 2021
Underestimated: Assessing CV Risk in Female Patients and Residual Risk in Patien
Underestimated: Assessing CV Risk in Female Patients and Residual Risk in Patients with CA
On Demand
33:35
September 29, 2021
Recommendations for Initiation of SGLT2i in Patients with HF and T2D
Recommendations for Initiation of SGLT2i in Patients with HF and T2D
On Demand
1:21:14
September 23, 2021
CAN-R³ : Initiative canadienne pour la réduction du risque résiduel : Nouveautés
CAN-R³ : Initiative canadienne pour la réduction du risque résiduel : Nouveautés dans la p
On Demand
59:27
September 21, 2021
Top 3 Conundrums in HF: Worsening Heart Failure
Top 3 Conundrums in HF: Worsening Heart Failure
On Demand
58:34
September 14, 2021
Closing the Gap with Novel and Emerging Therapies
Closing the Gap with Novel and Emerging Therapies
On Demand
31:10
September 13, 2021
Beyond Foundational Therapy: When to Reach in the Tool Box
Beyond Foundational Therapy: When to Reach in the Tool Box
On Demand
1:04:26
September 2, 2021
Contemporary Lipid Management for Secondary Prevention of ASCVD: Statin Intolera
Contemporary Lipid Management for Secondary Prevention of ASCVD: Statin Intolerance, Famil
On Demand
55:26
August 31, 2021
Top 3 Conundrums in HF: Hyperkalemia and Chronic Kidney Disease
Top 3 Conundrums in HF: Hyperkalemia and Chronic Kidney Disease
Podcast
July 16, 2021
Cardiovascular Update Podcasts (Apple Podcasts)
Cardiovascular Update Podcasts (Apple Podcasts)
On Demand
1:18:59
June 14, 2021
Current Dyslipidemia Management in Canada: What do the 2021 guidelines say?
Current Dyslipidemia Management in Canada: What do the 2021 guidelines say?
On Demand
1 hour
June 14, 2021
Current Dyslipidemia Management in Canada: What do the 2021 guidelines say?
Original air date: Monday, June 14, 2021
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Page
3
Page
4
Next page
››
Last page
Last »
